376 related articles for article (PubMed ID: 32443845)
1. Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression.
El-Far AH; Sroga G; Jaouni SKA; Mousa SA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443845
[TBL] [Abstract][Full Text] [Related]
2. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
3. Ousting RAGE in melanoma: A viable therapeutic target?
Syed DN; Aljohani A; Waseem D; Mukhtar H
Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306
[TBL] [Abstract][Full Text] [Related]
4. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
5. The Potential of Receptor for Advanced Glycation End Products (RAGE) as a Therapeutic Target for Lung Associated Diseases.
Khaket TP; Kang SC; Mukherjee TK
Curr Drug Targets; 2019; 20(6):679-689. PubMed ID: 30457049
[TBL] [Abstract][Full Text] [Related]
6. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
7. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
8. HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets.
Tesarova P; Kalousova M; Zima T; Tesar V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):1-10. PubMed ID: 26847418
[TBL] [Abstract][Full Text] [Related]
9. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
10. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.
Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875
[TBL] [Abstract][Full Text] [Related]
11. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
[TBL] [Abstract][Full Text] [Related]
12. The RAGE signaling in osteoporosis.
Zhou J; Liu S; Bi S; Kong W; Qian R; Xie X; Zeng M; Jiang X; Liao Z; Shuai M; Liu W; Cheng L; Wu M
Biomed Pharmacother; 2023 Sep; 165():115044. PubMed ID: 37354815
[TBL] [Abstract][Full Text] [Related]
13. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
[TBL] [Abstract][Full Text] [Related]
14. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Leung SS; Forbes JM; Borg DJ
Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases.
Singh H; Agrawal DK
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364135
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic perspective of morin protection against ketoprofen-induced gastric mucosal injury: Targeting HMGB1/RAGE/NF-κB, DJ-1/Nrf2/HO-1 and PI3K/mTOR pathways.
Arab HH; Saad MA; El-Sahar AE; Al-Shorbagy MY
Arch Biochem Biophys; 2020 Oct; 693():108552. PubMed ID: 32860758
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation.
Chen YJ; Chan DC; Chiang CK; Wang CC; Yang TH; Lan KC; Chao SC; Tsai KS; Yang RS; Liu SH
J Orthop Res; 2016 May; 34(5):791-800. PubMed ID: 26497299
[TBL] [Abstract][Full Text] [Related]
19. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
Sohn E; Kim J; Kim CS; Lee YM; Kim JS
Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
[TBL] [Abstract][Full Text] [Related]
20. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
